NewLink Genetics to Present at Upcoming Investor Conferences

AMES, Iowa, June 7 NewLink Genetics Corporation today announced that Charles Link, M.D., chairman and chief executive officer, will present at the following investor conferences:

Dr. Link will provide an overview of NewLink and its clinical development programs including HyperAcute®-Pancreas Immunotherapy which recently entered Phase 3 testing and presented Phase 2 data at ASCO.

About NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company applying innovative technologies to create new therapeutic agents for patients with cancer and infectious diseases. Its products are designed to enhance the patient's immune system, enabling the body's immune cells to target pathogens and diseased tissues. For more information please visit us at www.newlinkgenetics.com.

-- The 9th Annual Needham Healthcare Conference, Thursday, June 10, at 11:40 a.m. Eastern Time in New York City, NY. The presentation will be webcast live and available for replay at http://www.wsw.com/webcast/needham38/newlink/. -- The Wells Fargo Securities 2010 Healthcare Conference, Wednesday, June 23, at 1:00 p.m. Eastern Time in Boston, MA.

SOURCE NewLink Genetics Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...